Log In
Monday 21st May 2018

Drug boosting survival hopes for breast cancer sufferers

5th June 2007
Cancer drug Hercepin, could reduce the number of mastectomies if used alongside chemotherapy before women undergo surgery, a study has shown.  Women who suffer from a certain type of breast cancer, HER-2-positive, who are treated in this way were more likely to see tumours shrink substantially, meaning surgery that would conserve the bresat can be carrid out, according to new stattistics.

Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

M3 - For secure managed hosting over N3 or internet
© Mayden Foundation 2018